Technology
Saietta losses remain stable in first half
Saietta Group reported group income including grants of £1. 4m in its first half on Friday, up from £1. 3m year-on-year.
Insig AI gets listing on UN climate tool dashboard
Machine learning and data science specialist Insig AI has achieved listing on the United Nations Climate Risk Tool Dashboard, it announced on Thursday.
Tern investee Device Authority raising up to $7m
Technology investor Tern announced on Wednesday that Device Authority, in which it held a 53. 8% shareholding as of 21 November, has secured a series B fundraising round to raise up to $7m in new equity investment.
Agronomics posts strong set of full-year results
Cellular agriculture investor Agronomics reported a 14% increase in its net asset value per share in its final results on Wednesday, standing at 16. 94p on 30 June.
HgCapital to sell down stake in IRIS Software
HgCapital Trust (HGT) announced a partial sale of IRIS Software Group (IRIS) to LGP, a private equity firm based in Los Angeles, on Wednesday.
Novacyt facing delays in disposal of Yourgene Taiwan
Molecular diagnostics company Novacyt updated the market on the conditional disposal of its laboratory in Taiwan, which it acquired as part of its purchase of Yourgene Health on 8 September.
CAP-XX reports positive first-half trading
Supercapacitor and energy management system design and manufacturing specialist CAP-XX issued a positive trading update for its first half on Thursday.
Concurrent Technolgies secures £2.2m air defence contract
Concurrent Technologies announced a contract worth £2. 2m on Thursday for supplying VME processor boards to a significant multinational European defence prime contractor for integration into air defence systems.
Equals Group issues further shares for acquisition of Oonex
Equals Group updated the market on its acquisition of Oonex on Thursday, which it initially announced on 5 July.
IQGeo expands partnership with North American telecom
Geospatial software specialist IQGeo announced a significant expansion of its partnership with one of its key tier-one telecom customers in North America on Wednesday.
Belluscura confident in outlook after getting China approval
Belluscura has gained approval to distribute its X-PLOR portable oxygen concentrator (POC) in China, it announced on Wednesday, under a licensing agreement with InnoMax Medical Device Technologies.
Genedrive gets first product orders from several countries
Point-of-care pharmacogenetic testing company Genedrive has received its first orders for Genedrive MT-RNR1 products from several countries, it announced on Wednesday, including France, Austria, Greece, Saudi Arabia, Turkey, and the Netherlands.
Poolbeg makes promising progress with RSV programme
Poolbeg Pharma revealed promising results from the lab-based analysis and prioritisation of respiratory syncytial virus (RSV) drug targets and treatments on Wednesday, driven by its artificial intelligence (AI) programme.
Filtronic announces significant contract win
Aerospace, defence and telecoms infrastructure company and space-related products specialist Filtronic announced a significant contract win on Wednesday.
RUA Life Sciences makes progress with heart valve leaflet composite
RUA Life Sciences updated the market on its progress with the RUA leaflet composite on Wednesday.
FCA proposes changes to listing regime, bond markets
The Financial Conduct Authority (FCA) unveiled comprehensive proposals aimed at enhancing the accessibility, efficiency, and competitiveness of the UK's listing regime on Wednesday and improving the bond and derivatives markets.
Engage XR warns of contract delays
Virtual reality (VR) and metaverse technology company Engage XR warned of some contract delays in a trading update on Tuesday.
Netcall reports sustained positive trading momentum
Automation and customer engagement specialist Netcall said in an update on Tuesday that it saw sustained positive trading momentum in its first half, aligning with management expectations.
Avacta appoints new chief business officer
Oncology drugs and diagnostics specialist Avacta Group announced the appointment of Dr Simon Bennett as the chief business officer of its therapeutics division on Tuesday.
Tristel flags record first half, CEO to step down
Infection prevention products developer Tristel flagged a record-breaking first half in an update on Tuesday, with expected revenues of £20. 7m for the six months ending 31 December.